Literature DB >> 26136901

Association of BDNF and BCHE with Alzheimer's disease: Meta-analysis based on 56 genetic case-control studies of 12,563 cases and 12,622 controls.

Huihui Ji1, Dongjun Dai1, Yunliang Wang2, Danjie Jiang1, Xingyu Zhou1, Peipei Lin1, Xiaosui Ji1, Jinfeng Li2, Yuzheng Zhang2, Honglei Yin2, Rongrong Chen1, Lina Zhang1, Mingqing Xu3, Shiwei Duan1, Qinwen Wang1.   

Abstract

Alzheimer's disease (AD) is a common neurodegenerative disorder that can destroy the memory of sufferers and lead to distress for the individual and society. Brain-derived neurotrophic factor (BDNF) and butyrylcholinesterase (BCHE) are two genes associated with β-amyloid plaques and neurofibrillary tangles that are two key factors in the pathophysiology of AD. The aim of the current meta-analysis was to evaluate the association between BDNF Val66Met (rs6265), BDNF C270T (rs2030324) and BCHE-K (rs1803274) polymorphisms and AD. A comprehensive meta-analysis was performed using the online database PubMed without a time limitation. A total of 56 articles evaluating 12,563 cases and 12,622 controls were selected for the current meta-analysis. The results showed a moderate association of the BDNF C270T polymorphism with the risk of AD in Asians under a dominant model (P=0.03; odds ratio, 1.88; 95% confidence interval, 1.08-3.27). No other significant association was found during the meta-analysis for the other two polymorphisms (P>0.05). The current meta-analysis suggests that BDNF C270T is a risk factor for AD in Asians. This meta-analysis has been, to the best of our knowledge, the most comprehensive meta-analysis of BDNF Val66Met, BDNF C270T and BCHE-K to date.

Entities:  

Keywords:  Alzheimer's disease; Asians; BCHE-K; BDNF C270T; BDNF Val66Met; meta-analysis

Year:  2015        PMID: 26136901      PMCID: PMC4471730          DOI: 10.3892/etm.2015.2327

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  84 in total

1.  Association of butyrylcholinesterase K variant with cholinesterase-positive neuritic plaques in the temporal cortex in late-onset Alzheimer's disease.

Authors:  D J Lehmann; Z Nagy; S Litchfield; M C Borja; A D Smith
Journal:  Hum Genet       Date:  2000-04       Impact factor: 4.132

2.  A case-control study provides evidence of association for a common SNP rs974819 in PDGFD to coronary heart disease and suggests a sex-dependent effect.

Authors:  Jianqing Zhou; Yi Huang; R Stephanie Huang; Feiming Wang; Limin Xu; Yanping Le; Xi Yang; Weifeng Xu; Xiaoyan Huang; Jiangfang Lian; Shiwei Duan
Journal:  Thromb Res       Date:  2012-06-15       Impact factor: 3.944

3.  Genetic analysis of BDNF and TrkB gene polymorphisms in Alzheimer's disease.

Authors:  Saila Vepsäläinen; Eero Castren; Seppo Helisalmi; Susan Iivonen; Arto Mannermaa; Maarit Lehtovirta; Tuomo Hänninen; Hilkka Soininen; Mikko Hiltunen
Journal:  J Neurol       Date:  2005-02-23       Impact factor: 4.849

Review 4.  What causes alzheimer's disease?

Authors:  R A Armstrong
Journal:  Folia Neuropathol       Date:  2013       Impact factor: 2.038

5.  No association between the brain-derived neurotrophic factor 196 G>A or 270 C>T polymorphisms and Alzheimer's or Parkinson's disease.

Authors:  Marika S Saarela; Terho Lehtimaki; Juha O Rinne; Heini Huhtala; Riika Rontu; Antti Hervonen; Matias Roytta; Jukka-Pekka Ahonen; Kari M Mattila
Journal:  Folia Neuropathol       Date:  2006       Impact factor: 2.038

6.  Decreased levels of BDNF protein in Alzheimer temporal cortex are independent of BDNF polymorphisms.

Authors:  Jung Lee; Hiroaki Fukumoto; Jennifer Orne; Jochen Klucken; Susan Raju; Charles R Vanderburg; Michael C Irizarry; Bradley T Hyman; Martin Ingelsson
Journal:  Exp Neurol       Date:  2005-07       Impact factor: 5.330

7.  No association between the K variant of the butyrylcholinesterase gene and pathologically confirmed Alzheimer's disease.

Authors:  A B Singleton; G Smith; A M Gibson; R Woodward; R H Perry; P G Ince; J A Edwardson; C M Morris
Journal:  Hum Mol Genet       Date:  1998-05       Impact factor: 6.150

8.  Genetic variants in brain-derived neurotrophic factor associated with Alzheimer's disease.

Authors:  R Huang; J Huang; H Cathcart; S Smith; S E Poduslo
Journal:  J Med Genet       Date:  2007-02       Impact factor: 6.318

9.  Brain-derived neurotrophic factor, apolipoprotein E genetic variants and cognitive performance in Alzheimer's disease.

Authors:  Benedetta Nacmias; Carolina Piccini; Silvia Bagnoli; Andrea Tedde; Elena Cellini; Laura Bracco; Sandro Sorbi
Journal:  Neurosci Lett       Date:  2004-09-09       Impact factor: 3.046

10.  Association analysis of brain-derived neurotrophic factor Val66Met polymorphisms with Alzheimer's disease and age of onset.

Authors:  Shih-Jen Tsai; Chen-Jee Hong; Hsiu-Chih Liu; Tsung-Yun Liu; Li-En Hsu; Ching-Hua Lin
Journal:  Neuropsychobiology       Date:  2004       Impact factor: 2.328

View more
  17 in total

Review 1.  Neurotrophin Signaling and Stem Cells-Implications for Neurodegenerative Diseases and Stem Cell Therapy.

Authors:  Subrata Pramanik; Yanuar Alan Sulistio; Klaus Heese
Journal:  Mol Neurobiol       Date:  2016-11-05       Impact factor: 5.590

2.  Tau downregulates BDNF expression in animal and cellular models of Alzheimer's disease.

Authors:  Elyse Rosa; Sujeivan Mahendram; Yazi D Ke; Lars M Ittner; Stephen D Ginsberg; Margaret Fahnestock
Journal:  Neurobiol Aging       Date:  2016-08-31       Impact factor: 4.673

3.  Decreased peripheral brain-derived neurotrophic factor levels in Alzheimer's disease: a meta-analysis study (N=7277).

Authors:  X-Y Qin; C Cao; N X Cawley; T-T Liu; J Yuan; Y P Loh; Y Cheng
Journal:  Mol Psychiatry       Date:  2016-04-26       Impact factor: 15.992

Review 4.  The diabetic brain and cognition.

Authors:  Peter Riederer; Amos D Korczyn; Sameh S Ali; Ovidiu Bajenaru; Mun Seong Choi; Michael Chopp; Vesna Dermanovic-Dobrota; Edna Grünblatt; Kurt A Jellinger; Mohammad Amjad Kamal; Warda Kamal; Jerzy Leszek; Tanja Maria Sheldrick-Michel; Gohar Mushtaq; Bernard Meglic; Rachel Natovich; Zvezdan Pirtosek; Martin Rakusa; Melita Salkovic-Petrisic; Reinhold Schmidt; Angelika Schmitt; G Ramachandra Sridhar; László Vécsei; Zyta Beata Wojszel; Hakan Yaman; Zheng G Zhang; Tali Cukierman-Yaffe
Journal:  J Neural Transm (Vienna)       Date:  2017-08-01       Impact factor: 3.575

5.  Moderating Effects of BDNF Genetic Variants and Smoking on Cognition in PTSD Veterans.

Authors:  Gordana Nedic Erjavec; Matea Nikolac Perkovic; Lucija Tudor; Suzana Uzun; Zrnka Kovacic Petrovic; Marcela Konjevod; Marina Sagud; Oliver Kozumplik; Dubravka Svob Strac; Tina Peraica; Ninoslav Mimica; Ana Havelka Mestrovic; Denis Zilic; Nela Pivac
Journal:  Biomolecules       Date:  2021-04-26

6.  proBDNF is modified by advanced glycation end products in Alzheimer's disease and causes neuronal apoptosis by inducing p75 neurotrophin receptor processing.

Authors:  Catherine Fleitas; Gerard Piñol-Ripoll; Pau Marfull; Daniel Rocandio; Isidro Ferrer; Claire Rampon; Joaquim Egea; Carme Espinet
Journal:  Mol Brain       Date:  2018-11-14       Impact factor: 4.041

7.  Dose-dependent genotype effects of BDNF Val66Met polymorphism on default mode network in early stage Alzheimer's disease.

Authors:  Pin-Hsuan Lin; Shih-Jen Tsai; Chi-Wei Huang; Liu Mu-En; Shih-Wei Hsu; Chen-Chang Lee; Nai-Ching Chen; Ya-Ting Chang; Min-Yu Lan; Chiung-Chih Chang
Journal:  Oncotarget       Date:  2016-08-23

Review 8.  Critical Issues in BDNF Val66Met Genetic Studies of Neuropsychiatric Disorders.

Authors:  Shih-Jen Tsai
Journal:  Front Mol Neurosci       Date:  2018-05-15       Impact factor: 5.639

9.  Correlations of Four Genetic Single Nucleotide Polymorphisms in Brain-Derived Neurotrophic Factor with Posttraumatic Stress Disorder.

Authors:  Jun-Cheng Guo; Yi-Jun Yang; Min Guo; Xiao-Dan Wang; Yang Juan; Yun-Suo Gao; Lin-Qiu Fu; Xiang-Ling Jiang; Lin-Mei Fu; Tao Huang
Journal:  Psychiatry Investig       Date:  2018-03-19       Impact factor: 2.505

10.  Levels of Serum Brain-Derived Neurotropic Factor in Individuals at Ultra-High Risk for Psychosis-Findings from the Longitudinal Youth at Risk Study (LYRIKS).

Authors:  Jie Yin Yee; Tih-Shih Lee; Jimmy Lee
Journal:  Int J Neuropsychopharmacol       Date:  2018-08-01       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.